IS6630A - 5-Chloro-3- (4-methanesulfonylphenyl) -6'-methyl- [2,3 '] bipyridinyl in pure crystalline form and method of construction thereof - Google Patents

5-Chloro-3- (4-methanesulfonylphenyl) -6'-methyl- [2,3 '] bipyridinyl in pure crystalline form and method of construction thereof

Info

Publication number: IS6630A
Authority: IS; Iceland
Prior art keywords: methanesulfonylphenyl; bipyridinyl; chloro; methyl; construction
Prior art date: 2000-05-26

Application number

IS6630A

Other languages

Icelandic (is)

Other versions

IS2806B (en

Inventor

S. Crocker Louis

W. Davies Ian

G. Osifchin Richard

Kotliar Andrew

Original Assignee

Merck & Co., Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-26

Filing date

2002-11-20

Publication date

2002-11-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22772880&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS6630(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-11-20 Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.

2002-11-20 Publication of IS6630A publication Critical patent/IS6630A/en

2012-09-15 Publication of IS2806B publication Critical patent/IS2806B/en

Links

238000010276 construction Methods 0.000 title 1
MNJVRJDLRVPLFE-UHFFFAOYSA-N etoricoxib Chemical group C1=NC(C)=CC=C1C1=NC=C(Cl)C=C1C1=CC=C(S(C)(=O)=O)C=C1 MNJVRJDLRVPLFE-UHFFFAOYSA-N 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Virology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Reproductive Health (AREA)
Oncology (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IS6630A 2000-05-26 2002-11-20 5-Chloro-3- (4-methanesulfonylphenyl) -6'-methyl- [2,3 '] bipyridinyl in pure crystalline form and method of synthesis IS2806B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US20801700P	2000-05-26	2000-05-26
PCT/US2001/016566 WO2001092230A1 (en)	2000-05-26	2001-05-22	5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis

Publications (2)

Publication Number	Publication Date
IS6630A true IS6630A (en)	2002-11-20
IS2806B IS2806B (en)	2012-09-15

Family

ID=22772880

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6630A IS2806B (en)	2000-05-26	2002-11-20	5-Chloro-3- (4-methanesulfonylphenyl) -6'-methyl- [2,3 '] bipyridinyl in pure crystalline form and method of synthesis

Country Status (48)

Country	Link
EP (1)	EP1296951B1 (en)
JP (2)	JP3665053B2 (en)
KR (1)	KR100757699B1 (en)
CN (1)	CN1227233C (en)
AR (1)	AR028577A1 (en)
AT (1)	ATE483687T1 (en)
AU (2)	AU2001264804B2 (en)
BG (1)	BG65855B1 (en)
BR (1)	BRPI0111140B8 (en)
CA (1)	CA2410234C (en)
CR (1)	CR6606A (en)
CY (1)	CY1111440T1 (en)
CZ (1)	CZ20023888A3 (en)
DE (1)	DE60143197D1 (en)
DK (1)	DK1296951T3 (en)
EA (1)	EA004809B1 (en)
EE (1)	EE05242B1 (en)
EG (1)	EG24189A (en)
ES (1)	ES2351958T3 (en)
GC (1)	GC0000362A (en)
GE (1)	GEP20053492B (en)
GT (1)	GT200100091A (en)
HN (1)	HN2001000110A (en)
HR (1)	HRP20020934B1 (en)
HU (1)	HU228423B1 (en)
IL (1)	IL152582A0 (en)
IN (2)	IN2002CH02089A (en)
IS (1)	IS2806B (en)
JO (1)	JO2216B1 (en)
MA (1)	MA26919A1 (en)
ME (1)	ME00428B (en)
MX (1)	MX230696B (en)
MY (1)	MY123569A (en)
NO (1)	NO324495B1 (en)
NZ (1)	NZ522394A (en)
PA (1)	PA8516901A1 (en)
PE (1)	PE20011324A1 (en)
PH (1)	PH12001001175B1 (en)
PL (1)	PL358153A1 (en)
PT (1)	PT1296951E (en)
RS (1)	RS51541B (en)
SI (1)	SI1296951T1 (en)
SK (1)	SK287174B6 (en)
SV (1)	SV2002000462A (en)
TW (1)	TWI303634B (en)
UA (1)	UA73355C2 (en)
WO (1)	WO2001092230A1 (en)
ZA (1)	ZA200209558B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001037833A1 (en) *	1999-11-29	2001-05-31	Merck Frosst Canada & Co.	Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl
US6858631B1 (en)	1999-11-29	2005-02-22	Merck & Co., Inc.	Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl
US6521642B2 (en) *	2000-05-26	2003-02-18	Merck & Co., Inc.	5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis
PL2401253T3 (en)	2009-02-27	2016-05-31	Cadila Healthcare Ltd	A process for the preparation of etoricoxib
WO2012004677A1 (en)	2010-07-05	2012-01-12	Actavis Group Ptc Ehf	Solid state forms of etoricoxib salts
EA023286B1 (en)	2011-05-27	2016-05-31	ФАРМА ДжРС, Д.О.О.	Process for the preparation of polymorphic form i of etoricoxib
EP2773618A1 (en)	2011-11-03	2014-09-10	Cadila Healthcare Limited	An improved process for the preparation of etoricoxib and polymorphs thereof
WO2013075732A1 (en)	2011-11-21	2013-05-30	Synthon Bv	Process for making crystalline form i of etoricoxib
EP2601952A1 (en)	2011-12-07	2013-06-12	Zentiva, k.s.	Novel pharmaceutically acceptable salts and cocrystals of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl and their therapeutic uses
EP2887924B1 (en)	2012-08-27	2017-03-29	Cadila Healthcare Limited	Pharmaceutical compositions of etoricoxib
EP2888231B1 (en)	2012-08-27	2019-01-09	Glenmark Pharmaceuticals Limited	Process for preparation of crystalline etoricoxib
CN104418799A (en) *	2013-09-03	2015-03-18	天津药物研究院	Etoricoxib crystal as well as preparation method and application thereof
WO2015036550A1 (en)	2013-09-13	2015-03-19	Synthon B.V.	Process for making etoricoxib
CN106632003B (en) *	2015-12-31	2019-02-12	上海博志研新药物技术有限公司	A kind of preparation method of etoricoxib
CN108069896B (en) *	2016-11-11	2022-08-12	昆明积大制药股份有限公司	Preparation method of etoricoxib crystal form
CN107056691B (en) *	2017-06-21	2020-03-10	四川尚锐生物医药有限公司	Method for preparing etoricoxib crystal form V
CN107417599B (en) *	2017-06-21	2020-06-09	四川尚锐生物医药有限公司	Preparation method of etoricoxib crystal form
MX2017009660A (en)	2017-07-26	2017-11-23	Laboratorios Liomont S A De C V	Pharmaceutical composition with a range of ratio between tramadol chlorhydrate and etoricoxib for its administration for the treatment of pain.
CN107556231A (en) *	2017-09-23	2018-01-09	江苏正大清江制药有限公司	The crystal formation and preparation method for the salt that a kind of Etoricoxib is formed with paranitrobenzoic acid
CN107417600A (en) *	2017-09-26	2017-12-01	江苏正大清江制药有限公司	A kind of Etoricoxib and the novel crystal forms and preparation method of furancarboxylic acid forming salt
CN107898787B (en) *	2017-12-15	2018-11-30	扬子江药业集团上海海尼药业有限公司	A kind of pharmaceutical composition and its preparation and preparation method
MX2018013070A (en)	2017-12-29	2019-10-15	Gruenenthal Gmbh	Pharmaceutical combination comprising extended-release tramadol hydrochloride and immediate-release etoricoxib, and its use for the treatment of pain.
CN110143915A (en) *	2019-06-03	2019-08-20	蚌埠学院	A new crystal form of etoricoxib and p-toluenesulfonic acid salt and preparation method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5593994A (en) *	1994-09-29	1997-01-14	The Dupont Merck Pharmaceutical Company	Prostaglandin synthase inhibitors
US5739166A (en) *	1994-11-29	1998-04-14	G.D. Searle & Co.	Substituted terphenyl compounds for the treatment of inflammation
US5861419A (en) *	1996-07-18	1999-01-19	Merck Frosst Canad, Inc.	Substituted pyridines as selective cyclooxygenase-2 inhibitors
DE69724788T2 (en) *	1996-07-18	2004-08-05	Merck Frosst Canada & Co., Halifax	SUBSTITUTED PYRIDINE AS A SELECTIVE CYCLOOXYGENASE INHIBITOR
CN1178658C (en) *	1998-04-24	2004-12-08	麦克公司	Method for synthesizing cyclooxygenase-2 inhibitor
WO2001037833A1 (en) *	1999-11-29	2001-05-31	Merck Frosst Canada & Co.	Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl

2001
- 2001-05-15 PH PH12001001175A patent/PH12001001175B1/en unknown
- 2001-05-16 GC GCP20011369 patent/GC0000362A/en active
- 2001-05-16 AR ARP010102327A patent/AR028577A1/en unknown
- 2001-05-16 TW TW090111718A patent/TWI303634B/en not_active IP Right Cessation
- 2001-05-17 PE PE2001000443A patent/PE20011324A1/en not_active Application Discontinuation
- 2001-05-18 MY MYPI20012375 patent/MY123569A/en unknown
- 2001-05-21 GT GT200100091A patent/GT200100091A/en unknown
- 2001-05-22 AU AU2001264804A patent/AU2001264804B2/en not_active Expired
- 2001-05-22 EG EG20010540A patent/EG24189A/en active
- 2001-05-22 DE DE60143197T patent/DE60143197D1/en not_active Expired - Lifetime
- 2001-05-22 EA EA200201264A patent/EA004809B1/en not_active IP Right Cessation
- 2001-05-22 EP EP01939267A patent/EP1296951B1/en not_active Expired - Lifetime
- 2001-05-22 MX MXPA02011619 patent/MX230696B/en active IP Right Grant
- 2001-05-22 CZ CZ20023888A patent/CZ20023888A3/en unknown
- 2001-05-22 GE GE5012A patent/GEP20053492B/en unknown
- 2001-05-22 CA CA002410234A patent/CA2410234C/en not_active Expired - Lifetime
- 2001-05-22 AT AT01939267T patent/ATE483687T1/en active
- 2001-05-22 BR BR0111140-0 patent/BRPI0111140B8/en not_active IP Right Cessation
- 2001-05-22 PA PA20018516901A patent/PA8516901A1/en unknown
- 2001-05-22 JO JO200179A patent/JO2216B1/en active
- 2001-05-22 NZ NZ522394A patent/NZ522394A/en not_active IP Right Cessation
- 2001-05-22 HU HU0302336A patent/HU228423B1/en unknown
- 2001-05-22 IL IL15258201A patent/IL152582A0/en active IP Right Grant
- 2001-05-22 RS YUP-894/02A patent/RS51541B/en unknown
- 2001-05-22 HR HR20020934A patent/HRP20020934B1/en not_active IP Right Cessation
- 2001-05-22 DK DK01939267.9T patent/DK1296951T3/en active
- 2001-05-22 PT PT01939267T patent/PT1296951E/en unknown
- 2001-05-22 ME MEP-2008-638A patent/ME00428B/en unknown
- 2001-05-22 SI SI200130982T patent/SI1296951T1/en unknown
- 2001-05-22 ES ES01939267T patent/ES2351958T3/en not_active Expired - Lifetime
- 2001-05-22 CN CNB018101372A patent/CN1227233C/en not_active Ceased
- 2001-05-22 JP JP2002500844A patent/JP3665053B2/en not_active Expired - Lifetime
- 2001-05-22 EE EEP200200655A patent/EE05242B1/en unknown
- 2001-05-22 UA UA20021210537A patent/UA73355C2/en unknown
- 2001-05-22 AU AU6480401A patent/AU6480401A/en active Pending
- 2001-05-22 PL PL01358153A patent/PL358153A1/en not_active Application Discontinuation
- 2001-05-22 KR KR20027015871A patent/KR100757699B1/en not_active Expired - Lifetime
- 2001-05-22 SK SK1670-2002A patent/SK287174B6/en not_active IP Right Cessation
- 2001-05-22 WO PCT/US2001/016566 patent/WO2001092230A1/en not_active Ceased
- 2001-05-23 SV SV2001000462A patent/SV2002000462A/en active IP Right Grant
- 2001-05-23 HN HN2001000110A patent/HN2001000110A/en unknown
2002
- 2002-03-08 CR CR6606A patent/CR6606A/en unknown
- 2002-10-31 BG BG107237A patent/BG65855B1/en unknown
- 2002-11-20 IS IS6630A patent/IS2806B/en unknown
- 2002-11-25 ZA ZA200209558A patent/ZA200209558B/en unknown
- 2002-11-26 NO NO20025674A patent/NO324495B1/en not_active IP Right Cessation
- 2002-12-16 IN IN2089CH2002 patent/IN2002CH02089A/en unknown
- 2002-12-23 MA MA26971A patent/MA26919A1/en unknown
2004
- 2004-09-10 JP JP2004263913A patent/JP4142621B2/en not_active Expired - Lifetime
2007
- 2007-11-12 IN IN5103CH2007 patent/IN2007CH05103A/en unknown
2011
- 2011-01-04 CY CY20111100010T patent/CY1111440T1/en unknown

Also Published As

Publication number	Publication date
SK287174B6 (en)	2010-02-08
JP3665053B2 (en)	2005-06-29
CY1111440T1 (en)	2015-08-05
ES2351958T3 (en)	2011-02-14
EA004809B1 (en)	2004-08-26
DK1296951T3 (en)	2011-01-24
AR028577A1 (en)	2003-05-14
KR100757699B1 (en)	2007-09-13
BRPI0111140B1 (en)	2018-03-13
NO20025674D0 (en)	2002-11-26
PA8516901A1 (en)	2002-04-25
CZ20023888A3 (en)	2003-02-12
EP1296951A1 (en)	2003-04-02
DE60143197D1 (en)	2010-11-18
CA2410234C (en)	2008-05-13
CR6606A (en)	2006-02-06
NO324495B1 (en)	2007-10-29
MXPA02011619A (en)	2003-03-27
PE20011324A1 (en)	2002-01-28
BG107237A (en)	2003-05-30
CA2410234A1 (en)	2001-12-06
PL358153A1 (en)	2004-08-09
EE05242B1 (en)	2009-12-15
GEP20053492B (en)	2005-04-25
EP1296951B1 (en)	2010-10-06
TWI303634B (en)	2008-12-01
IN2007CH05103A (en)	2008-08-27
HK1058932A1 (en)	2004-06-11
BRPI0111140B8 (en)	2021-05-25
YU89402A (en)	2005-11-28
BR0111140A (en)	2005-01-11
GT200100091A (en)	2001-12-28
RS51541B (en)	2011-06-30
WO2001092230A1 (en)	2001-12-06
GC0000362A (en)	2007-03-31
HN2001000110A (en)	2002-03-06
HUP0302336A2 (en)	2003-11-28
PT1296951E (en)	2010-12-07
ZA200209558B (en)	2003-10-28
JO2216B1 (en)	2004-10-07
EG24189A (en)	2008-10-08
AU6480401A (en)	2001-12-11
SV2002000462A (en)	2002-03-08
SI1296951T1 (en)	2011-01-31
MA26919A1 (en)	2004-12-20
PH12001001175B1 (en)	2006-08-10
JP2005047927A (en)	2005-02-24
ATE483687T1 (en)	2010-10-15
AU2001264804B2 (en)	2006-04-06
EA200201264A1 (en)	2003-04-24
BG65855B1 (en)	2010-03-31
MX230696B (en)	2005-09-19
IS2806B (en)	2012-09-15
JP2004501116A (en)	2004-01-15
IL152582A0 (en)	2003-05-29
KR20030003762A (en)	2003-01-10
IN2002CH02089A (en)	2005-02-25
ME00428B (en)	2011-10-10
CN1443168A (en)	2003-09-17
HU228423B1 (en)	2013-03-28
JP4142621B2 (en)	2008-09-03
HRP20020934A2 (en)	2005-02-28
MY123569A (en)	2006-05-31
UA73355C2 (en)	2005-07-15
CN1227233C (en)	2005-11-16
EE200200655A (en)	2004-08-16
SK16702002A3 (en)	2003-05-02
NZ522394A (en)	2004-05-28
NO20025674L (en)	2002-11-26
HRP20020934B1 (en)	2012-01-31

Publication	Publication Date	Title
IS6630A (en)	2002-11-20	5-Chloro-3- (4-methanesulfonylphenyl) -6'-methyl- [2,3 '] bipyridinyl in pure crystalline form and method of construction thereof
NO20032726D0 (en)	2003-06-16	Quinazoline derivatives, medicaments containing these compounds, their use and method of preparation thereof
DK199900554A (en)	2000-01-03	Paroxetine salts, process for their preparation, pharmaceutical compositions comprising these and uses thereof
DK1180518T3 (en)	2007-05-21	5-pyridyl-1,3-azole compounds, process for their preparation and use thereof
NO20032332L (en)	2003-05-22	Benzodiazepine derivative compounds, method of preparation and use thereof
DK200300344U1 (en)	2003-12-12	Amlodipine maleate and pharmaceutical composition containing amlodipine maleate
ATE466485T1 (en)	2010-05-15	FOOD CONTAINING A GEL COMPOSITION AND PRODUCTION METHOD
IS2821B (en)	2013-02-15	Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, processes for their preparation and formulations containing them
PL356911A1 (en)	2004-07-12	Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
DK1122254T3 (en)	2005-08-29	4-sulfonamide piperidine derivatives, process for their preparation and pharmaceutical compositions containing them
IL154240A0 (en)	2003-07-31	4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
DK1307237T3 (en)	2007-07-02	Perfluoroalkyl-containing complexes with polar groups, process for their preparation and use
DK1282639T3 (en)	2005-12-12	Polyamide nucleic acid derivatives, agents and methods for their preparation
DK1261625T3 (en)	2006-04-18	Memnopeptides, a method for their preparation and their use
IS7844A (en)	2005-05-12	Crystalline fumarate salts of 1-azabicyclo [2.2.2] octyl substituted furo [2,3-c] pyridinyl carboxamide and formulations and their preparations
IL162524A0 (en)	2005-11-20	Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application
DK1086077T3 (en)	2004-08-02	New antiestrogens, methods for their preparation and their pharmaceutical use
NO20031108L (en)	2003-05-08	Pharmaceutical composition for the treatment of headache, and method for the preparation of the preparation
NO20014393D0 (en)	2001-09-10	1,3,4-oxadiazole derivatives and process for their preparation
PT1192163E (en)	2004-01-30	DITIEPINO¬6,5-B \| PYRIDINES AND COMPOSITIONS AND RELATED METHODS
DK1259523T3 (en)	2004-03-22	Pluraflavins and derivatives thereof, method of preparation and use thereof
IL156160A0 (en)	2003-12-23	Klainetins and their derivatives, method for their preparation and use thereof
DK1146044T3 (en)	2004-12-27	CNS-active cyclobutaindole carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them
NO20023687D0 (en)	2002-08-02	1,3,4-oxadiazole derivatives and process for their preparation
NO20022482D0 (en)	2002-05-24	2-arylquinoline derivatives, method and therapeutic use thereof